CLINICAL_TRIALS
trial_result
· 2022-08-04
Clinical Trial Update: Carnosine for Peripheral Arterial Disease [Phase 2]
Summary
Phase 2 trial of carnosine for peripheral arterial disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Louisville | Conditions: Peripheral Arterial Disease | Phase 2 | Status: COMPLETED